AGIOS PHARMACEUTICALS, INC. (AGIO) › Shareholders' EquityAGIOS PHARMACEUTICALS, INC. (AGIO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: -$29.59M2011: -$52.78M2012: -$72.02M2013: $131.48M2014: $424.37M2015: $345.12M2016: $358.59M2017: $375.50M2018: $687.54M2019: $640.53M2020: $399.50M2021: $1.29B2022: $1.10B2023: $811.02M2024: $1.54B2025: $1.19B$1.19B2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$1.19B-22.6%2024$1.54B+90.0%2023$811.02M-26.3%2022$1.10B-14.8%2021$1.29B+223.4%2020$399.50M-37.6%2019$640.53M-6.8%2018$687.54M+83.1%2017$375.50M+4.7%2016$358.59M+3.9%2015$345.12M-18.7%2014$424.37M+222.8%2013$131.48M+282.6%2012-$72.02M-36.5%2011-$52.78M-78.4%2010-$29.59M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share